Related Experiment Video
Updated: Jun 13, 2025

Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model
Published on: April 3, 2016
A Method to Estimate the Efficacy of Orthokeratology Lenses in Slowing Myopia Progression
Jacinto Santodomingo-Rubido1, Sin-Wan Cheung, César Villa-Collar
1Global R&D (J.S.-R.), Menicon Co., Ltd, Nagoya, Japan; School of Optometry (S.-W.C.), The Hong Kong Polytechnic University, Hung Hom, Hong Kong, China; and Faculty of Health Sciences (C.V.-C.), Universidad Europea, Madrid, Spain.
Purpose:
To estimate the efficacy of orthokeratology contact lenses in slowing myopia progression.
Methods:
Prospective data from 101 to 88 children, aged 6 to 12 years and with myopia between -0.50 and -5.00 D, who completed 2 years of orthokeratology and single-vision spectacle lens wear, respectively, were analyzed post hoc. The relationship between changes in mean spherical refractive error (MSE) and axial length (AL) in the control group (spectacle wearers) was assessed and subsequently used to convert changes in AL into changes in MSE for the orthokeratology group.
Results:
Relatively strong correlations were found between changes in MSE and AL relative to baseline for the control group at all time points, including 0.5-, 1-, 1.5-, and 2-year intervals after lens wear (all P <0.001). The estimated mean changes in MSE (± SD) at 24 months in comparison with baseline for orthokeratology and control groups were -0.77±0.51 and -1.24±0.71 D, respectively. Thus, it is estimated that orthokeratology lenses slow the increase in MSE versus the control by -0.47 D.
Conclusions:
This study estimates that orthokeratology lenses reduce myopia progression by -0.47 D after 2 years of lens wear in comparison with spectacle wear. These results might be useful for eye care practitioners engaged in fitting orthokeratology lenses for myopia management.
Related Concept Videos
Focusing of Light in the Eye
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...

